Cilia: a new therapeutic target for type 1 diabetes?

Ente: WT

Scadenza: 2028-04-01

Importo max: 344.701 €

Paese: EU

Descrizione

Type 1 diabetes (T1D) is a chronic autoimmune disease where the immune system destroys insulin-producing β-cells in pancreatic islets, leading to lifelong insulin dependence and increased risk of multi-organ complications. Despite advances in care, the triggers of β-cell destruction remain poorly un

Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.